Drug Pricing Dynamics

John discusses the complexities of drug pricing, emphasizing that pharmaceutical companies prioritize profit maximization over consumer affordability. He highlights the role of middlemen, like pharmaceutical benefits managers, in manipulating prices through rebates, which further complicates the market. The focus shifts from providing fair access to medications to navigating a convoluted system that often leaves consumers at a disadvantage.